Precision Medicine Software Market Size, Share & Growth Report by 2034

Table Of Content

Executive Summary

Research Scope & Segmentation

Research Objectives
Limitations & Assumptions
Market Scope & Segmentation
Currency & Pricing Considered

Market Opportunity Assessment

Emerging Regions / Countries
Emerging Companies
Emerging Applications / End Use

Market Trends

Drivers
Market Warning Factors
Latest Macro Economic Indicators
Geopolitical Impact
Technology Factors

Market Assessment

Porters Five Forces Analysis
Value Chain Analysis

Regulatory Framework

North America
Europe
APAC
Middle East and Africa
LATAM

ESG Trends

Global Precision Medicine Software Market Size Analysis

Global Precision Medicine Software Market Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
  2. Implementation & integration
    1. Implementation & integration By Value
  3. Clinical interpretation & reporting services
    1. Clinical interpretation & reporting services By Value
  4. Validation & regulatory support
    1. Validation & regulatory support By Value
  5. Data curation / annotation services
    1. Data curation / annotation services By Value
  6. Others
    1. Others By Value
By Delivery Mode
1. Introduction
  1. Delivery Mode By Value
2. Cloud-based
  1. By Value
3. On-premise
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Cardiology
  1. By Value
4. Neurology / CNS
  1. By Value
5. Rare & Genetic Disorders
  1. By Value
6. Infectious Diseases (pathogen genomics)
  1. By Value
7. Immunology / Autoimmune
  1. By Value
8. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. AI / Machine Learning models & Generative AI
  1. By Value
3. Rule-based engines (clinical guidelines, pathways)
  1. By Value
4. Cloud & Containerized Pipelines (Kubernetes/Docker)
  1. By Value
5. High-performance compute / HPC for genomics
  1. By Value
6. Interoperability / FHIR / HL7 integration
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Pharmaceutical & Biotech companies
  1. By Value
4. Diagnostic Laboratories & Genomic Service Providers
  1. By Value
5. Contract Research Organizations (CROs)
  1. By Value
6. Others
  1. By Value

North America Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
  2. Implementation & integration
    1. Implementation & integration By Value
  3. Clinical interpretation & reporting services
    1. Clinical interpretation & reporting services By Value
  4. Validation & regulatory support
    1. Validation & regulatory support By Value
  5. Data curation / annotation services
    1. Data curation / annotation services By Value
  6. Others
    1. Others By Value
By Delivery Mode
1. Introduction
  1. Delivery Mode By Value
2. Cloud-based
  1. By Value
3. On-premise
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Cardiology
  1. By Value
4. Neurology / CNS
  1. By Value
5. Rare & Genetic Disorders
  1. By Value
6. Infectious Diseases (pathogen genomics)
  1. By Value
7. Immunology / Autoimmune
  1. By Value
8. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. AI / Machine Learning models & Generative AI
  1. By Value
3. Rule-based engines (clinical guidelines, pathways)
  1. By Value
4. Cloud & Containerized Pipelines (Kubernetes/Docker)
  1. By Value
5. High-performance compute / HPC for genomics
  1. By Value
6. Interoperability / FHIR / HL7 integration
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Pharmaceutical & Biotech companies
  1. By Value
4. Diagnostic Laboratories & Genomic Service Providers
  1. By Value
5. Contract Research Organizations (CROs)
  1. By Value
6. Others
  1. By Value
U.S.
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
    2. Implementation & integration
      1. Implementation & integration By Value
    3. Clinical interpretation & reporting services
      1. Clinical interpretation & reporting services By Value
    4. Validation & regulatory support
      1. Validation & regulatory support By Value
    5. Data curation / annotation services
      1. Data curation / annotation services By Value
    6. Others
      1. Others By Value
2. By Delivery Mode
  1. Introduction
    1. Delivery Mode By Value
  2. Cloud-based
    1. By Value
  3. On-premise
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Cardiology
    1. By Value
  4. Neurology / CNS
    1. By Value
  5. Rare & Genetic Disorders
    1. By Value
  6. Infectious Diseases (pathogen genomics)
    1. By Value
  7. Immunology / Autoimmune
    1. By Value
  8. Others
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. AI / Machine Learning models & Generative AI
    1. By Value
  3. Rule-based engines (clinical guidelines, pathways)
    1. By Value
  4. Cloud & Containerized Pipelines (Kubernetes/Docker)
    1. By Value
  5. High-performance compute / HPC for genomics
    1. By Value
  6. Interoperability / FHIR / HL7 integration
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Pharmaceutical & Biotech companies
    1. By Value
  4. Diagnostic Laboratories & Genomic Service Providers
    1. By Value
  5. Contract Research Organizations (CROs)
    1. By Value
  6. Others
    1. By Value
Canada

Europe Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
  2. Implementation & integration
    1. Implementation & integration By Value
  3. Clinical interpretation & reporting services
    1. Clinical interpretation & reporting services By Value
  4. Validation & regulatory support
    1. Validation & regulatory support By Value
  5. Data curation / annotation services
    1. Data curation / annotation services By Value
  6. Others
    1. Others By Value
By Delivery Mode
1. Introduction
  1. Delivery Mode By Value
2. Cloud-based
  1. By Value
3. On-premise
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Cardiology
  1. By Value
4. Neurology / CNS
  1. By Value
5. Rare & Genetic Disorders
  1. By Value
6. Infectious Diseases (pathogen genomics)
  1. By Value
7. Immunology / Autoimmune
  1. By Value
8. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. AI / Machine Learning models & Generative AI
  1. By Value
3. Rule-based engines (clinical guidelines, pathways)
  1. By Value
4. Cloud & Containerized Pipelines (Kubernetes/Docker)
  1. By Value
5. High-performance compute / HPC for genomics
  1. By Value
6. Interoperability / FHIR / HL7 integration
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Pharmaceutical & Biotech companies
  1. By Value
4. Diagnostic Laboratories & Genomic Service Providers
  1. By Value
5. Contract Research Organizations (CROs)
  1. By Value
6. Others
  1. By Value
U.K.
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
    2. Implementation & integration
      1. Implementation & integration By Value
    3. Clinical interpretation & reporting services
      1. Clinical interpretation & reporting services By Value
    4. Validation & regulatory support
      1. Validation & regulatory support By Value
    5. Data curation / annotation services
      1. Data curation / annotation services By Value
    6. Others
      1. Others By Value
2. By Delivery Mode
  1. Introduction
    1. Delivery Mode By Value
  2. Cloud-based
    1. By Value
  3. On-premise
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Cardiology
    1. By Value
  4. Neurology / CNS
    1. By Value
  5. Rare & Genetic Disorders
    1. By Value
  6. Infectious Diseases (pathogen genomics)
    1. By Value
  7. Immunology / Autoimmune
    1. By Value
  8. Others
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. AI / Machine Learning models & Generative AI
    1. By Value
  3. Rule-based engines (clinical guidelines, pathways)
    1. By Value
  4. Cloud & Containerized Pipelines (Kubernetes/Docker)
    1. By Value
  5. High-performance compute / HPC for genomics
    1. By Value
  6. Interoperability / FHIR / HL7 integration
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Pharmaceutical & Biotech companies
    1. By Value
  4. Diagnostic Laboratories & Genomic Service Providers
    1. By Value
  5. Contract Research Organizations (CROs)
    1. By Value
  6. Others
    1. By Value
Germany
France
Spain
Italy
Russia
Nordic
Benelux
Rest of Europe

APAC Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
  2. Implementation & integration
    1. Implementation & integration By Value
  3. Clinical interpretation & reporting services
    1. Clinical interpretation & reporting services By Value
  4. Validation & regulatory support
    1. Validation & regulatory support By Value
  5. Data curation / annotation services
    1. Data curation / annotation services By Value
  6. Others
    1. Others By Value
By Delivery Mode
1. Introduction
  1. Delivery Mode By Value
2. Cloud-based
  1. By Value
3. On-premise
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Cardiology
  1. By Value
4. Neurology / CNS
  1. By Value
5. Rare & Genetic Disorders
  1. By Value
6. Infectious Diseases (pathogen genomics)
  1. By Value
7. Immunology / Autoimmune
  1. By Value
8. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. AI / Machine Learning models & Generative AI
  1. By Value
3. Rule-based engines (clinical guidelines, pathways)
  1. By Value
4. Cloud & Containerized Pipelines (Kubernetes/Docker)
  1. By Value
5. High-performance compute / HPC for genomics
  1. By Value
6. Interoperability / FHIR / HL7 integration
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Pharmaceutical & Biotech companies
  1. By Value
4. Diagnostic Laboratories & Genomic Service Providers
  1. By Value
5. Contract Research Organizations (CROs)
  1. By Value
6. Others
  1. By Value
China
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
    2. Implementation & integration
      1. Implementation & integration By Value
    3. Clinical interpretation & reporting services
      1. Clinical interpretation & reporting services By Value
    4. Validation & regulatory support
      1. Validation & regulatory support By Value
    5. Data curation / annotation services
      1. Data curation / annotation services By Value
    6. Others
      1. Others By Value
2. By Delivery Mode
  1. Introduction
    1. Delivery Mode By Value
  2. Cloud-based
    1. By Value
  3. On-premise
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Cardiology
    1. By Value
  4. Neurology / CNS
    1. By Value
  5. Rare & Genetic Disorders
    1. By Value
  6. Infectious Diseases (pathogen genomics)
    1. By Value
  7. Immunology / Autoimmune
    1. By Value
  8. Others
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. AI / Machine Learning models & Generative AI
    1. By Value
  3. Rule-based engines (clinical guidelines, pathways)
    1. By Value
  4. Cloud & Containerized Pipelines (Kubernetes/Docker)
    1. By Value
  5. High-performance compute / HPC for genomics
    1. By Value
  6. Interoperability / FHIR / HL7 integration
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Pharmaceutical & Biotech companies
    1. By Value
  4. Diagnostic Laboratories & Genomic Service Providers
    1. By Value
  5. Contract Research Organizations (CROs)
    1. By Value
  6. Others
    1. By Value
Korea
Japan
India
Australia
Taiwan
South East Asia
Rest of Asia-Pacific

Middle East and Africa Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
  2. Implementation & integration
    1. Implementation & integration By Value
  3. Clinical interpretation & reporting services
    1. Clinical interpretation & reporting services By Value
  4. Validation & regulatory support
    1. Validation & regulatory support By Value
  5. Data curation / annotation services
    1. Data curation / annotation services By Value
  6. Others
    1. Others By Value
By Delivery Mode
1. Introduction
  1. Delivery Mode By Value
2. Cloud-based
  1. By Value
3. On-premise
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Cardiology
  1. By Value
4. Neurology / CNS
  1. By Value
5. Rare & Genetic Disorders
  1. By Value
6. Infectious Diseases (pathogen genomics)
  1. By Value
7. Immunology / Autoimmune
  1. By Value
8. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. AI / Machine Learning models & Generative AI
  1. By Value
3. Rule-based engines (clinical guidelines, pathways)
  1. By Value
4. Cloud & Containerized Pipelines (Kubernetes/Docker)
  1. By Value
5. High-performance compute / HPC for genomics
  1. By Value
6. Interoperability / FHIR / HL7 integration
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Pharmaceutical & Biotech companies
  1. By Value
4. Diagnostic Laboratories & Genomic Service Providers
  1. By Value
5. Contract Research Organizations (CROs)
  1. By Value
6. Others
  1. By Value
UAE
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
    2. Implementation & integration
      1. Implementation & integration By Value
    3. Clinical interpretation & reporting services
      1. Clinical interpretation & reporting services By Value
    4. Validation & regulatory support
      1. Validation & regulatory support By Value
    5. Data curation / annotation services
      1. Data curation / annotation services By Value
    6. Others
      1. Others By Value
2. By Delivery Mode
  1. Introduction
    1. Delivery Mode By Value
  2. Cloud-based
    1. By Value
  3. On-premise
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Cardiology
    1. By Value
  4. Neurology / CNS
    1. By Value
  5. Rare & Genetic Disorders
    1. By Value
  6. Infectious Diseases (pathogen genomics)
    1. By Value
  7. Immunology / Autoimmune
    1. By Value
  8. Others
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. AI / Machine Learning models & Generative AI
    1. By Value
  3. Rule-based engines (clinical guidelines, pathways)
    1. By Value
  4. Cloud & Containerized Pipelines (Kubernetes/Docker)
    1. By Value
  5. High-performance compute / HPC for genomics
    1. By Value
  6. Interoperability / FHIR / HL7 integration
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Pharmaceutical & Biotech companies
    1. By Value
  4. Diagnostic Laboratories & Genomic Service Providers
    1. By Value
  5. Contract Research Organizations (CROs)
    1. By Value
  6. Others
    1. By Value
Turkey
Saudi Arabia
South Africa
Egypt
Nigeria
Rest of MEA

LATAM Market Analysis

Introduction
By Component
1. Introduction
  1. Component By Value
2. Software
  1. By Value
3. Services
  1. By Value
  2. Implementation & integration
    1. Implementation & integration By Value
  3. Clinical interpretation & reporting services
    1. Clinical interpretation & reporting services By Value
  4. Validation & regulatory support
    1. Validation & regulatory support By Value
  5. Data curation / annotation services
    1. Data curation / annotation services By Value
  6. Others
    1. Others By Value
By Delivery Mode
1. Introduction
  1. Delivery Mode By Value
2. Cloud-based
  1. By Value
3. On-premise
  1. By Value
By Application
1. Introduction
  1. Application By Value
2. Oncology
  1. By Value
3. Cardiology
  1. By Value
4. Neurology / CNS
  1. By Value
5. Rare & Genetic Disorders
  1. By Value
6. Infectious Diseases (pathogen genomics)
  1. By Value
7. Immunology / Autoimmune
  1. By Value
8. Others
  1. By Value
By Technology
1. Introduction
  1. Technology By Value
2. AI / Machine Learning models & Generative AI
  1. By Value
3. Rule-based engines (clinical guidelines, pathways)
  1. By Value
4. Cloud & Containerized Pipelines (Kubernetes/Docker)
  1. By Value
5. High-performance compute / HPC for genomics
  1. By Value
6. Interoperability / FHIR / HL7 integration
  1. By Value
7. Others
  1. By Value
By End Use
1. Introduction
  1. End Use By Value
2. Hospitals
  1. By Value
3. Pharmaceutical & Biotech companies
  1. By Value
4. Diagnostic Laboratories & Genomic Service Providers
  1. By Value
5. Contract Research Organizations (CROs)
  1. By Value
6. Others
  1. By Value
Brazil
1. By Component
  1. Introduction
    1. Component By Value
  2. Software
    1. By Value
  3. Services
    1. By Value
    2. Implementation & integration
      1. Implementation & integration By Value
    3. Clinical interpretation & reporting services
      1. Clinical interpretation & reporting services By Value
    4. Validation & regulatory support
      1. Validation & regulatory support By Value
    5. Data curation / annotation services
      1. Data curation / annotation services By Value
    6. Others
      1. Others By Value
2. By Delivery Mode
  1. Introduction
    1. Delivery Mode By Value
  2. Cloud-based
    1. By Value
  3. On-premise
    1. By Value
3. By Application
  1. Introduction
    1. Application By Value
  2. Oncology
    1. By Value
  3. Cardiology
    1. By Value
  4. Neurology / CNS
    1. By Value
  5. Rare & Genetic Disorders
    1. By Value
  6. Infectious Diseases (pathogen genomics)
    1. By Value
  7. Immunology / Autoimmune
    1. By Value
  8. Others
    1. By Value
4. By Technology
  1. Introduction
    1. Technology By Value
  2. AI / Machine Learning models & Generative AI
    1. By Value
  3. Rule-based engines (clinical guidelines, pathways)
    1. By Value
  4. Cloud & Containerized Pipelines (Kubernetes/Docker)
    1. By Value
  5. High-performance compute / HPC for genomics
    1. By Value
  6. Interoperability / FHIR / HL7 integration
    1. By Value
  7. Others
    1. By Value
5. By End Use
  1. Introduction
    1. End Use By Value
  2. Hospitals
    1. By Value
  3. Pharmaceutical & Biotech companies
    1. By Value
  4. Diagnostic Laboratories & Genomic Service Providers
    1. By Value
  5. Contract Research Organizations (CROs)
    1. By Value
  6. Others
    1. By Value
Mexico
Argentina
Chile
Colombia
Rest of LATAM

Competitive Landscape

Precision Medicine Software Market Share By Players
M&A Agreements & Collaboration Analysis

Market Players Assessment

Tempus Labs, Inc.
1. Overview
2. Business Information
3. Revenue
4. ASP
5. SWOT Analysis
6. Recent Developments
Foundation Medicine, Inc.
SOPHiA GENETICS SA
Fabric Genomics, Inc.
PierianDx, Inc.
Syapse, Inc.
GenomOncology LLC
2bPrecise, LLC
IQVIA, Inc.
Genedata AG
Illumina, Inc.
QIAGEN N.V.
Flatiron Health, Inc.
Guardant Health, Inc.
IBM
Owkin, Inc.
Inspirata, Inc.
Strata Oncology, Inc.
Oracle Cerner
Siemens Healthineers AG
Others

Research Methodology

Research Data
1. Secondary Data
  1. Major secondary sources
  2. Key data from secondary sources
2. Primary Data
  1. Key data from primary sources
  2. Breakdown of primaries
3. Secondary And Primary Research
  1. Key industry insights
Market Size Estimation
1. Bottom-Up Approach
2. Top-Down Approach
3. Market Projection
Research Assumptions
1. Assumptions
Limitations
Risk Assessment